Rice's Omid Veiseh has been awarded a $2.2 million grant from the Gates Foundation to develop implantable cell factory platforms that can deliver therapeutic antibodies over extended periods.
CRISPR-based technique unlocks healing power of mitochondria for heart failure therapy
Rice researchers and collaborators induced heart cells to increase mitochondria production to optimal levels, opening a path toward a new therapy for heart failure.
A team of researchers led by Rice bioengineer Omid Veiseh has been awarded up to $18.2 million in funding from the Advanced Research Projects Agency for Health to develop a first-of-its-kind regenerative treatment aimed at restoring damaged lymphatic vessels and potentially curing lymphedema, a condition that affects more than 10 million Americans.
Rice’s SynthX Center leads up to $18M effort to transform lymphatic imaging
Rice's SynthX Center is leading a new effort to improve how doctors detect and diagnose lymphatic diseases.
Platform to map living brain noninvasively takes next big step
A technology designed to read gene activity in the brain from a simple blood test has now cleared a major translational hurdle.
Day in the life: Health sciences senior follows research toward clinical psychology
Isabella Bourtin balances GRE prep, lab work and upper-level courses as she pivots from pre-med ambitions toward a future in clinical psychology.
More precise DNA base editing could improve treatment for cystic fibrosis
Researchers at Rice and collaborators have refined a DNA base-editing technology to make it more precise, a step that could improve prospects for treating some patients with cystic fibrosis.
New Rice-led perspective charts path to next-generation water and energy membranes
A new invited perspective in Nature Water, led by Rice researchers and international collaborators, discusses the future of membrane science.
Noninvasive paths to complex brain science: Rice bioengineer named Sloan Research Fellow
Rice bioengineer Jerzy Szablowski has been named a 2026 Alfred P. Sloan Research Fellow in chemistry, one of the most competitive honors for early career scientists in the U.S. and Canada.
Metabolic clues emerge from new molecular map of Alzheimer’s
Rice scientists have developed the first complete, label-free molecular atlas of the Alzheimer’s brain in an animal model.
Rice360 and African universities inspiring new generation of inventors and global health innovators
When the Rice360 Institute for Global Health Technologies launched the first design studios in partner universities across Africa during Phase 1 of the NEST360 initiative, the vision was clear: create sustainable, university-based ecosystems that empower students to design, prototype and commercialize lifesaving technologies inspired by real needs in their own communities.
Rice lab to help develop bioprinted kidneys as part of ARPA-H PRINT program award
Rice bioengineer Antonios Mikos is part of a team of researchers led by the Wake Forest Institute for Regenerative Medicine awarded up to $24.8 million over five years to help address the nation’s growing organ donor shortage by bioprinting on-demand kidney tissues.
Rice introduces new graduate certificate in global health technologies
Rice is expanding its commitment to health innovation with the launch of a new graduate certificate in global health technologies, now open to all Rice graduate students regardless of discipline.
From Honduras to Houston: Rice student engineering care, access and belonging
Graduate student Sofia Urbina is working to advance wearable rehabilitation technologies while ensuring they reach communities like those in Honduras, where she grew up.
Rice’s Jesse H. Jones Graduate School of Business today announced the launch of its Graduate Certificate in Healthcare Management program, a 10-month, credit-bearing professional credential designed for current and aspiring leaders seeking deep expertise in the business of healthcare. Situated at the crossroads of Houston’s renowned Texas Medical Center and global healthcare innovation, the program blends rigorous business fundamentals with healthcare-specific strategy, operations and management.